Freeline Therapeutics Holdings Plc

NASDAQ FRLN

Data sourced from iex and EODHD
Download Data

Freeline Therapeutics Holdings Plc Cash Flow Statement 2016 - 2022

This table shows the Cash Flow Statement for Freeline Therapeutics Holdings Plc going from 2016 until 2022. The cash flow statement is a financial statement that shows the inflow and outflow of cash and cash equivalents from a company's operating, investing, and financing activities over a specified period. It provides crucial information about a company's ability to generate and manage cash, which is essential for its day-to-day operations, investments, and debt obligations.
Cash Flow Statement Trend Unit 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31
Net Income
M -89 -140 -96 -54 -33 -12 -
Depreciation and Amortization
M 2 2 2 2 1 1 -
Non-Cash Items (Other)
M -5 0 0 - - - -
Operating Cash Flow
M -78 -108 -95 -52 -26 -14 -3
Capital Expenditures
M -7 -4 -3 -3 -4 -1 0
Net Acquisitions
M - - - - - - -
Other Investing Activities
M - - - - - 0 0
Investing Cash Flow
M - - - - - 0 0
Repayment/Issuance of Debt (Net)
M - - - - - - -
Equity Repurchase (Common, Net)
M - - - - - - -
Dividends Paid
M - - - - - - -
Other Financial Activities
M 0 -1 81 -3 38 - -
Financing Cash Flow
M 0 -1 81 -3 38 - -
Exchange Rate Adjustment
M - - - - - - -
Beginning Cash
M 119 232 75 16 9 - -
Ending Cash
M 49 119 232 75 16 9 -
Stock-Based Compensation
M 5 11 6 1 0 - -
Issuance/Purchase of Shares
M - - - - - - -
Capital Stock Change
M 27 0 243 115 38 - -
Working Capital
M 37 108 239 77 17 11 5
Free Cash Flow
M -85 -112 -97 -55 -30 - -

StockViz Staff

September 20, 2024

Any question? Send us an email